ConductScience.org, home

Gene · 3455

NIH grants2,761

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleIFNAR2 papersNewest fiscal year
T32AI007163Training Program in Basic Immunology32025
T32AI007647Training Program in Mechanisms of Virus-Host Interactions32025
T32AR007080Scientist Training in Rheumatology Research32025
T32CA009547TRAINING IN THE IMMUNOBIOLOGY AND MOLECULAR CELL BIOLOGY OF CANCER32025
U19AI128949Human anti-viral immune responses in tissues and circulation32025
U19AI135972SARS-CoV adaptations through a Systems Biology Lens (SYBIL)32025
U19AI162568Determinants of TB control, relapse and reinfection32025
UL1TR002345Washington University Institute of Clinical and Translational Sciences32025
ZIAAI000940Pathogenesis of Tick-Borne Flavivirus Infections32025
ZIAAI001089Viral Hemorrhagic Fevers: Disease Modeling and Transmission32025
ZIACL009010DC Partnership for HIV/AIDS Progress (DC PFAP)32025
ZIAHL006001Framingham Project/Levy32025
ZICAI001051Infectious Diseases Collaborative Technological Research Resources - Bethesda32025
ZICAR041181Translational Immunology research: a support for clinical immunological research32025
ZIGAI001048Veterinary Services Core for Infectious Diseases Research- RML32025
I01CX000916Signaling Pathways and Therapeutic Targeting of Leukemic Cells22025
K24AR076975Linking Disease Mechanisms and Outcomes in Rheumatic Diseases22025
OT2OD033760Comprehensive reference atlas construction, geolocation and data integration for HuBMAP HIVE [5 of 5]22025
P01AI063302The intersection of innate and adaptive immunity to intracellular pathogens22025
P01AI106695Protective immunity following dengue virus natural infections and vaccination22025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/3455/grants?page=4